No evidence on MRI that intensive BP control cuts Alzheimer’s risk: study
Further results from the SPRINT MIND trial show a 'counterintuitive' association with decreased hippocampal volume
Intensive blood pressure control does not lead to clinically meaningful differences in brain imaging biomarkers of Alzheimer’s disease on MRI, according to data from a US trial.
In fact, for one biomarker — hippocampal volume — those in the intensive BP control arm fared worse, with a statistically significant decrease at the four-year follow-up.
